HEALTHSTREAM INC (HSTM) Forecast, Price Target & Analyst Ratings
NASDAQ:HSTM • US42222N1037
20.625 USD
+0.11 (+0.56%)
Last: Mar 12, 2026, 11:45 AM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HEALTHSTREAM INC (HSTM).
Forecast Snapshot
Consensus Price Target
$33.15
+ 60.73% Upside
Next Earnings Forecast
Release DateMay 4, 2026
PeriodQ1 / 2026
EPS Estimate$0.17
Revenue Estimate80.964M
ChartMill Buy Consensus
78.18%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$33.15
Upside
+ 60.73%
From current price of $20.63 to mean target of $33.15, Based on 11 analyst forecasts
Low
$25.25
Median
$33.15
High
$42.00
Price Target Revisions
1 Month
0.00%
3 Months
-4.41%
Price Target Summary
11 Wall Street analysts provided a forecast for the next 12 months for HSTM. The average price target is 33.15 USD. This implies a price increase of 60.73% is expected in the next year compared to the current price of 20.625.
The average price target has been revised downward by 4.41% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
78.18%
HSTM was analyzed by 11 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about HSTM.
In the previous month the buy percentage consensus was at a similar level.
HSTM was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-12-17 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-08-07 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-05-15 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-02-26 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-02-06 | JMP Securities | Reiterate | Market Perform -> Market Perform |
| 2024-10-23 | Barclays | Maintains | Overweight -> Overweight |
| 2024-10-23 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2024-07-24 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2023-12-06 | JMP Securities | Initiate | Market Perform |
| 2023-02-22 | Canaccord Genuity | Maintains | Hold |
| 2021-04-28 | Canaccord Genuity | Maintains | Hold |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 4, 2026
PeriodQ1 / 2026
EPS Estimate$0.17
Revenue Estimate80.964M
Revenue Q2Q10.18%
EPS Q2Q22.04%
Number of Analysts6
Next Earnings Revisions
Revenue (1 Month)
3.10%
Revenue (3 Months)
3.10%
EPS (1 Month)
1.52%
EPS (3 Months)
4.69%
Next Earnings Summary
HSTM is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is 0.17 USD and the consensus revenue estimate is 80.96M USD.
The next earnings revenue estimate has been revised upward by 3.1% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 279.063M 4.60% | 291.646M 4.51% | 304.064M 4.26% | 331.28M 8.95% | 347.59M 4.92% | 346.74M -0.24% | 365.81M 5.50% | 387.76M 6.00% | 409.09M 5.50% | 429.54M 5.00% | |
| EBITDA YoY % growth | 57.095M 13.40% | 62.53M 9.52% | 63.714M 1.89% | 77.906M 22.27% | 83.447M 7.11% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 16.019M 29.19% | 21.287M 32.89% | 20.236M -4.94% | 27.033M 33.59% | 29.092M 7.62% | 31.207M 7.27% | 34.752M 11.36% | 38.776M 11.58% | 42.954M 10.77% | 47.249M 10.00% | |
| Operating Margin | 5.74% | 7.30% | 6.66% | 8.16% | 8.37% | 9.00% | 9.50% | 10.00% | 10.50% | 11.00% | |
| EPS YoY % growth | 0.50 28.21% | 0.66 32.00% | 0.70 6.06% | 0.77 9.29% | 0.88 14.67% | N/A | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 0.17 22.04% | 0.19 4.83% | 0.22 9.65% | 0.20 11.45% |
| Revenue Q2Q % growth | 80.964M 10.18% | 82.052M 10.29% | 81.256M 6.25% | 81.722M 2.53% |
| EBITDA Q2Q % growth | 18.657M 23.29% | 19.461M -29.25% | 20.092M -49.78% | 19.876M -56.68% |
| EBIT Q2Q % growth | 6.408M 46.37% | 7.002M 18.96% | 7.819M 3.33% | 7.502M 212.19% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
4.19%
Revenue Next 5 Year
4.81%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
HEALTHSTREAM INC / HSTM Forecast FAQ
What is the price target for HSTM stock?
11 analysts have analysed HSTM and the average price target is 33.15 USD. This implies a price increase of 60.73% is expected in the next year compared to the current price of 20.625.
What is the next earnings date for HSTM stock?
HEALTHSTREAM INC (HSTM) will report earnings on 2026-05-04.
What are the consensus estimates for HSTM stock next earnings?
The consensus EPS estimate for the next earnings of HEALTHSTREAM INC (HSTM) is 0.17 USD and the consensus revenue estimate is 80.96M USD.
What is the expected long term growth rate for HEALTHSTREAM INC (HSTM)?
The expected long term growth rate for HEALTHSTREAM INC (HSTM) is 4.19%.